The First Ethiopian Case Report of Post-COVID-19 Vaccine Associated Guillain-Barre Syndrome

Domaine:

healthcare

Type de record:

paper

Créateur:

ZekEdeAmsAsc

Éditeur:

Eno

Hôte:

We report the first Ethiopian case of a rare neurologic complication, Guillain-Barre Syndrome (GBS), following Ad26.COV2.S (Janssen/Johnson & Johnson) COVID-19 vaccination. Although a temporal relationship is identified, a causal relationship between the Janssen/Johnson & Johnson COVID-19 vaccine and GBS is not established. Clinician awareness of this association is essential to early GBS diagnosis and treatment. Further, global data collection is important to ascertain the true magnitude and possible causality of post-COVID-19 vaccine associated GBS.

A retrospective analysis of the clinical profile and factors associated with mortality and poor hospital outcomes in adult Guillain–Barre syndrome patients

Abstract Guillain–Barré syndrome (GBS) is an acute autoimmune polyneuropathy with substantial geogr

Hutchinson‐Gilford Progeria syndrome: Report of the first Togolese case

Abstract The aim of this article is to describe the first case of Hutchinson‐Gilford Progeria Syndr

Post Malaria Neurological Syndrome: Unknown, Underestimated, or Underdiagnosed? First Report Done in Gambia

Post-malaria neurological syndrome (PMNS) is a rare self-limiting neurological complication that can

First Case of COVID-19-Associated Collapsing Glomerulopathy in Sub-Saharan Africa

Although the lungs remain the main target of SARS-CoV-2, other organs, such as kidneys, can be affec

A typical Kawasaki syndrome in COVID-19 infection: a case report of a multisystem inflammatory syndrome in a child (MIS-C)

The emergence of COVID-19 by a novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) in 2

COVID-19 vaccine hesitancy among Ethiopian healthcare workers

Introduction COVID-19 poses significant health and economic threat prompting international firms t